Understanding the Proposed Changes

The CMS proposal centers around two key restrictions. First, any hospital offering comprehensive gender-affirming care – including puberty blockers, hormone therapy, and surgical interventions – could be excluded from Medicare and Medicaid participation. Given that nearly all hospitals in the United States participate in these programs, this provision poses an existential threat to access. Second, the rule seeks to prohibit Medicaid and CHIP funds from covering gender-affirming care for individuals under the age of 18 and 19, respectively.

Dannie Ceseña, Director of the California LGBTQ Health and Human Services Network, stated, “The Trump administration has made it blatantly obvious that it does not care about the health and wellness of the American people and our access to health care. Instead of lowering costs or extending critical health care subsidies, it is choosing to attack transgender and gender-diverse youth.” Ceseña emphasized that the proposed actions disregard “decades of scientific, peer-reviewed research,” and pledged continued support for transgender and gender-diverse youth, their families, and the medical professionals who serve them.

Amanda McAllister-Wallner, Executive Director of Health Access, characterized the announcement as “a further escalation of their cruel, dangerous, and medically unfounded attacks on transgender youth.” She argued that the rules “fly in the face of decades of consensus from medical professionals” and represent a dangerous overreach of bureaucratic authority, overriding the expertise of doctors, parents, and the young people themselves. McAllister-Wallner further asserted that the administration is “essentially holding our hospitals hostage to force their political agenda on us all.”

What is Gender-Affirming Care?

Gender-affirming care encompasses a range of medical, psychological, and social support services designed to help individuals align their lives with their gender identity. This can include social transition (e.g., using preferred pronouns and names), puberty blockers (reversible medications that delay the onset of puberty), hormone therapy, and, in some cases, surgical interventions. Medical organizations like the American Academy of Pediatrics and the American Medical Association recognize gender-affirming care as safe, effective, and medically necessary for many transgender and gender-diverse individuals.

Did You Know? The World Professional Association for Transgender Health (WPATH) publishes Standards of Care for the Health of Transgender and Gender Diverse People, which are internationally recognized guidelines for providing gender-affirming care.

California’s Response and Protections

Despite the federal proposals, California remains a staunch defender of transgender rights and access to care. State law explicitly prohibits healthcare providers and insurers from discriminating against transgender, gender diverse, or intersex individuals. Furthermore, California’s shield laws, including SB 345 and SB 923, provide crucial protections for healthcare providers offering gender-affirming care, shielding them from legal repercussions stemming from out-of-state investigations or disciplinary actions.

These protections are particularly significant given the increasing number of states enacting restrictive laws targeting transgender youth. California’s commitment to safeguarding access to care serves as a beacon of hope for individuals and families facing discrimination and hostility elsewhere.

But what does this mean for the future of healthcare access for transgender youth across the country? And how can individuals and organizations effectively advocate for policies that protect and affirm the rights of this vulnerable population?

Pro Tip: Stay informed about legislative developments and advocacy opportunities by following organizations like the National Center for Transgender Equality (https://transequality.org/) and GLAAD (https://www.glaad.org/).

Frequently Asked Questions

• What is the primary goal of the proposed CMS rule regarding gender-affirming care?

  The primary goal is to restrict access to medically necessary gender-affirming care for transgender and gender-diverse youth by potentially excluding hospitals that provide this care from Medicare and Medicaid and by limiting funding for such care.

• How will these proposed rules impact hospitals that offer gender-affirming care?

  Hospitals could be barred from participating in Medicare and Medicaid, potentially leading to significant financial hardship and reduced access to care for all patients, not just transgender youth.

• What protections are in place for transgender individuals in California?

  California law prohibits discrimination in healthcare based on gender identity, and shield laws protect providers from out-of-state legal actions related to gender-affirming care.

• What can I do to oppose these proposed rules?

  You can submit comments to CMS during the public comment period, which is open until [Date 60 days from Dec 19, 2023]. Your voice matters!

• Where can I find more information about the proposed rules?

  You can find details about the Conditions of Participation Rule and the Medicaid Funding Restriction Rule on the Federal Register website.